Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

30 Mar 2015 07:00

RNS Number : 7560I
Diploma PLC
30 March 2015
Β 

Β 

DIPLOMAΒ PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

Β 

FOR IMMEDIATE RELEASE

Β 

30 March 2015

Β 

Β 

DIPLOMA PLC

Β 

TRADING UPDATE

Β 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a trading update for the six months ending 31 March 2015, ahead of going into its close period.

Β 

Trading Summary

The businesses acquired during the past year have made a good contribution to the Group's overall results and revenues for the six months ending 31 March 2015 are expected to be ca. 9% ahead of the comparable period. The acquired businesses have contributed ca. 9% to Group revenues, but currency volatility has continued to impact the Group's results, reducing revenues by ca. 2%. On an underlying basis, after adjusting for the impact of currencies and acquisitions, revenues are expected to increase by ca. 2%.

Β 

The main driver to revenue growth has been from the Seals businesses where revenues have benefited both from acquisitions completed last year and from strong demand, particularly in the North American Seals businesses. In Life Sciences, the recent acquisition of the TPD business has contributed to a strong increase in headline revenues. Underlying growth has been flat as the Canadian Healthcare businesses have faced tougher markets, with hospitals increasing their focus on controlling costs as they approach the end of their budgetary fiscal year. In Controls, underlying revenues have reduced against the strong prior year comparative, reflecting lower activity in the Motorsport and Aerospace fastener sectors and softer European industrial markets.

Β 

Currency movements have continued to impact the Group's results on both a translational and transactional basis. Further depreciation against UK sterling, relative to last year, of the Euro and the Canadian and Australian dollars, more than offset the impact from the appreciation of the US dollar. The transactional impact from currency depreciation on the Life Sciences businesses has contributed to a slightly lower Group operating margin, as anticipated.

Β 

Financial Position

After spending ca. Β£34m on completing the acquisitions of TPD (Life Sciences) in October 2014 and Kubo (Seals) in early March 2015, the Group expects to have net debt of ca. Β£18m at 31 March 2015, compared with cash balances of Β£21.3m at 30 September 2014.

Β 

The Board will provide a further update on trading prospects for the year when the Group's Half Year's results are announced on Monday, 11 May 2015.

Β 

Β 

Β 

Β 

Note: A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

Β 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

Β 

Β 

NOTE TO EDITORS:

Β 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

Β 

Diploma's businesses are focussed on supplying essential products and services which are funded by the customers' operating rather than their capital budgets, providing recurring income and stable revenue growth.

Β 

Our businesses design their individual business models to closely meet the requirements of their customers, offering a blend of high quality customer service, deep technical support and value adding activities. By supplying essential solutions, not just products, we build strong long term relationships with our customers and suppliers, which support attractive and sustainable margins.

Β 

Finally we encourage an entrepreneurial culture in our businesses through our decentralised management structure. We want our managers to feel that they have the freedom to run their own businesses, while being able to draw on the support and resources of a larger group. These essential values ensure that decisions are made close to the customer and that the businesses are agile and responsive to changes in the market and the competitive environment.

Β 

The Group employs ca. 1,300 employees and its principal operating businesses are located in the UK, Germany, US, Canada and Australia.

Β 

Over the last five years, the Group has grown adjusted earnings per share at an average of 20% p.a. through a combination of organic growth and acquisitions. Diploma is a member of the FTSE 250 with a market capitalisation of ca. Β£900m.

Β 

Β 

Further information on Diploma PLC, together with a copy of this Announcement, is available at www.diplomaplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTPGUWGWUPAGQM
Date   Source Headline
9th Apr 201410:09 amRNSHolding(s) in Company
25th Mar 20149:48 amRNSDirector/PDMR Shareholding
24th Mar 20147:00 amRNSTrading Statement
26th Feb 20144:18 pmRNSHolding(s) in Company
12th Feb 20144:09 pmRNSHolding(s) in Company
5th Feb 20144:55 pmRNSHolding(s) in Company
31st Jan 201410:23 amRNSHolding(s) in Company
16th Jan 201411:00 amRNSHolding(s) in Company
15th Jan 20145:04 pmRNSResolutions of AGM
15th Jan 20147:00 amRNSInterim Management Statement
9th Dec 20134:20 pmRNSDirector/PDMR Shareholding
9th Dec 20134:10 pmRNSDirector/PDMR Shareholding
6th Dec 20137:00 amRNSAnnual Financial Report and Notice of AGM
22nd Nov 20132:00 pmRNSDirector/PDMR Shareholding
18th Nov 201311:21 amRNSAppointment of Director
18th Nov 20137:00 amRNSPreliminary Announcement of Results
4th Nov 20134:40 pmRNSSecond Price Monitoring Extn
4th Nov 20134:35 pmRNSPrice Monitoring Extension
1st Oct 201310:00 amRNSDirectorate Change
26th Sep 20137:00 amRNSTrading Statement
10th Sep 20137:00 amRNSInvestor Event
30th Jul 20137:00 amRNSInterim Management Statement
29th Jul 20134:00 pmRNSBoard Committee Changes
23rd Jul 20132:00 pmRNSHolding(s) in Company
25th Jun 201310:15 amRNSDirector/PDMR Shareholding
17th Jun 201311:30 amRNSHolding(s) in Company
30th May 20137:00 amRNSAppointment of Non-Executive Directors
15th May 20138:05 amRNSDirector/PDMR Shareholding
13th May 20137:00 amRNSHalf Yearly Report
19th Apr 20137:00 amRNSNotice of Results
2nd Apr 20134:00 pmRNSDirector Declaration
25th Mar 20137:00 amRNSTrading Statement
22nd Mar 20139:42 amRNSBoard Committee Change
14th Mar 201312:00 pmRNSEmployee Benefit Trust Dealings
21st Jan 20132:21 pmRNSDirector/PDMR Shareholding
16th Jan 20134:35 pmRNSResult of AGM
16th Jan 20137:00 amRNSInterim Management Statement
20th Dec 20124:11 pmRNSDirector/PDMR Shareholding
19th Dec 201210:56 amRNSDirector/PDMR Shareholding
10th Dec 20121:47 pmRNSAnnual Financial Report and Notice of AGM
21st Nov 20124:00 pmRNSDirector/PDMR Shareholding
19th Nov 20127:00 amRNSPreliminary Announcement
14th Nov 20127:00 amRNSAppointment of Non-Executive Director
24th Sep 20127:00 amRNSPre-Close Update
21st Sep 20121:24 pmRNSHolding(s) in Company
21st Sep 20127:00 amRNSCompany Secretary Change
10th Aug 20123:30 pmRNSDirector/PDMR Shareholding
30th Jul 20127:00 amRNSInterim Management Statement
5th Jul 20124:00 pmRNSHolding(s) in Company
14th May 201211:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.